Cochrane

We have a once-in-a-generation opportunity to create a global step change in evidence synthesis, and we invite you to be part of it. In collaboration with JBI and The Campbell Collaboration, Cochrane is hosting an open meeting on Monday, 30 September 2024, to discuss how we can collectively advance towards a global evidence ecosystem. This meeting builds on the insightful discussions from the recent Global Evidence Summit. 🌐 Learn more about our vision and what we aim to achieve: https://lnkd.in/gy4aScFu 🙋♂️ Register your interest to attend. A meeting link will be sent to all participants after registration: https://lnkd.in/gan72mbh Now is the time to transform evidence synthesis for the people who rely on it most. Join us in shaping this change on a global scale!

🎉 Congratulations to Kylie Hunter, winner of the 2024 Thomas C Chalmers Award for Best Short Oral Presentation! 🏆 The Thomas C Chalmers Award is presented to an investigator who demonstrates originality, high-quality science, and contributions to advancing systematic review methods. Kylie’s winning presentation at the Global Evidence Summit #GES2024 introduced the Individual Participant Data (IPD) Integrity Tool, a powerful new tool designed to detect integrity issues in randomised controlled trials. 🎤 "This recognition from Cochrane has already been instrumental in helping to disseminate our tool and raise awareness about integrity issues – an area I’m very passionate about." 👉 You can read more about Kylie's work -- including the paper the oral presentation was based on - here: https://lnkd.in/gk3WdQ9H 👏 👏 👏 Join us in congratulating Kylie in the comments! 

Writing a Cochrane Review is a powerful way to contribute to evidence-based healthcare. Whether you're new to Cochrane or returning as an author, let's get started on your journey together! 🤓 🤝 📚 Find out how to propose a new Cochrane Review, access free resources, and begin making an impact in global health. 🔗 Learn more and start your Cochrane author journey today: https://lnkd.in/geacTQzw #Cochrane #EvidenceBasedHealthcare #Research #CochraneAuthor #SystematicReview #CochraneReview

We’re thrilled to announce that the Cochrane Colloquium is set to take place in India in October 2026! 🎉 This landmark event will focus on the key themes: Bridging Gaps, Global Evidence, Local Impact, and Equitable Action. It’s a fantastic opportunity for the global healthcare evidence community to unite, share insights, and drive meaningful change. 🎤 Catherine Spencer OBE MBA, CEO of Cochrane, shared her enthusiasm: “The 2026 Cochrane Colloquium will be pivotal for anyone involved in evidence-based healthcare. These themes are crucial for advancing evidence production, implementation, and policy, and we are excited to develop a programme that addresses these vital areas.” 🎤 Prof Dr Neeta Mohanty from Cochrane India expressed excitement about hosting the Colloquium."It is an honour to invite you all to India for the 2026 Colloquium. Attending previous Colloquia has been a highlight for our team and we are looking forward to welcoming you and being your warm hosts." With an engaging programme and impactful conversations on the horizon, this Colloquium promises to be a pivotal gathering for everyone involved in evidence-based healthcare. 📧 Don’t miss out on the latest updates—sign up for our newsletter and stay connected with all the exciting developments! https://lnkd.in/gF5DaAJ3 📰 Learn more and join us on this exciting journey: https://lnkd.in/gWMBnHwC

A recent Cochrane review confirms that an inexpensive drug, costing just £5 per dose, can prevent cerebral palsy in premature babies. Despite its effectiveness, this drug remains inconsistently available worldwide. A new Cochrane Library Editorial calls for accelerated global implementation of magnesium sulphate to protect preterm babies from cerebral palsy. Learn more: 📰 News item - https://lnkd.in/gweEaNBB 💬 Cochrane Library Editorial - https://lnkd.in/gS7cnEEX 📃 Cochrane review and plain language summary - https://lnkd.in/gTipq3Fn

At the United Nations #SummitOfTheFuture, two major funding bodies announced £54.2 million of new funding for evidence synthesis: £45 million from Wellcome Trust and £9.2 million from UK Research and Innovation. The announcements represent a significant investment in evidence synthesis to help tackle global inequity and address the UN’s Sustainable Development Goals. 🎤  Karla Soares-Weiser, Cochrane Editor-in-Chief: “This significant investment has the potential to catalyze a step change in evidence synthesis, making it more timely, relevant and equitable. Cochrane has a proud history of advancing evidence synthesis, and we stand ready to support this vital global effort. I am especially excited at the potential to reduce global inequities in both producing and accessing high-quality evidence.” 🎤 Tari Turner, Cochrane Australia, "It’s fantastic to see this global commitment to living evidence and recognition of Cochrane's leadership in this area. The new funding is fantastic news for both evidence synthesis professionals and decision-makers who need up-to-date evidence. Living reviews come with many opportunities and challenges which we identified in our pilot programmes, and it’s great to see them getting the attention they deserve.” Learn more: https://lnkd.in/gt64bC_p #UNGA79 #UNGA #GlobalGoals #HealthInequities #GlobalHealth #EvidenceSynthesis #SDGs

Medicines to reduce pain and discomfort during #SpinalTap in #newborns 💊 👶 The Cochrane Neonatal Group produces and updates Cochrane Reviews to provide comprehensive coverage of the evidence on the care of #babies and #infants. 🎧 In this #CochranePodcast, we present an important topic in #neonatal care: the management of pain and discomfort during spinal taps in newborns, for which a new Cochrane review was published in September 2023. Two of the authors, Ehsan Hedayati and Sara Pessano, talk about the findings in about 4 minutes. https://lnkd.in/dmqiythD 🤓 Read the full #SystamticReview and #PlainLanguage summary: https://lnkd.in/gnkjPkmx Pessano S, Romantsik O, Olsson E, Hedayati E, Bruschettini M. Pharmacological interventions for the management of pain and discomfort during lumbar puncture in newborn infants. Cochrane Database of Systematic Reviews 2023, Issue 9. Art. No.: CD015594. DOI: 10.1002/14651858.CD015594.pub2.

Cochrane is standing along side global leaders at the #SummitOfTheFuture Cochrane's Editor-in-Chief, Karla Soares-Weiser delivered powerful remarks on the role of evidence in tackling global challenges. At Cochrane, we believe in creating inclusive and equitable evidence—ensuring that those most affected by health challenges are not only part of the process but also benefit from evidence-based decisions that address health disparities. As Karla highlighted: 'None of us can achieve this alone. If we are to contribute to the Sustainable Development Goals, we must work together.' Cochrane is committed to inclusive evidence that supports decision-making for those most affected by health challenges. We are grateful to global leaders and partners for this shared commitment. Let's continue working together to ensure evidence drives impactful decisions and advances global health for all. #UNGA79 #UNGA #GlobalGoals #SDGs #SustainableDevelopmentGoals

We’re always excited to see passionate individuals join us in our mission to improve health outcomes globally through trusted evidence synthesis. Together, we can make a lasting impact on public health and advance evidence-based decision-making for a healthier world. 💜 Interested in joining us? You can be part of this global effort too! Learn more and join us at https://lnkd.in/eP2_y3Z7

Cochrane is incredibly energised by Wellcome Trust's landmark commitment to advancing evidence synthesis! 🎉 🤓 💜 At Cochrane, we believe that timely, accessible, and coordinated evidence is crucial for improving global health and achieving the United Nations Sustainable Development Goals #SDGs. Wellcome’s pledge to transform how #EvidenceSynthesis is done will drive the change we all want to see—faster, more efficient, and equitable access to evidence that can improve lives. As a leader in 'producing gold-standard evidence', we’re particularly excited about the investment in common data infrastructure and tools that will enable the use of #LivingEvidence models. This will foster global collaboration and ensure that evidence can continuously inform decision-making. 🔗 Read more about this groundbreaking initiative: https://lnkd.in/gqt8NjCj